Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology

被引：0
|
作者：
Malinauskiene, Vaidota [1 ]
Zuzo, Anastasija [2 ]
Liakina, Valentina [1 ,3 ]
Kazenaite, Edita [1 ]
Stundiene, Ieva [1 ]
机构：
[1] Vilnius Univ, Inst Clin Med, Fac Med, Clin Gastroenterol Nephrourol & Surg, 2 Santariskiu Str, LT-01513 Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, LT-01513 Vilnius, Lithuania
[3] Vilnius Tech, Fac Fundamental Sci, Dept Chem & Bioengn, LT-10223 Vilnius, Lithuania
来源：
WORLD JOURNAL OF CLINICAL CASES | 2023年 / 11卷 / 21期
关键词：
Menstrual disorders; Inflammatory bowel disease; Adalimumab; Infliximab; Anti-tumor necrosis factor-& alpha; TNF-ALPHA; ENDOMETRIOSIS; EPIDEMIOLOGY; ADALIMUMAB; EXPRESSION; CROHNS; PHASE; PAIN;
D O I：
10.12998/wjcc.v11.i21.4989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Inflammatory bowel disease (IBD) is a chronic condition that affects young individuals in their reproductive years. It may have long-term implications on their reproductive, sexual, and mental health. IBD has been related to menstrual abnormalities. Furthermore, the administration of biological therapy can also result in gynecological issues in addition to the disease itself. The purpose of this review was to present potential menstrual cycle problems in patients with IBD, as well as the impact of adalimumab and other anti-tumor necrosis factor medications on gynecological pathology.
引用
收藏
页码：4989 / 4995
页数：7
相关论文
共 50 条
  • [31] Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era
    Campos, Sara
    Portela, Francisco
    Sousa, Paula
    Sofia, Carlos
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (11) : 1313 - 1319
  • [32] FREQUENCY AND CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE IN SPONDYLOARTHRITIS WITH BIOLOGICAL THERAPY
    Calvo, I.
    Ibarguengoitia, O.
    Montero, D.
    Vega, L.
    Garcia-Vivar, M. L.
    Ruiz, E.
    Torre, I.
    Fernandez, O.
    Blanco, J. M.
    Intxaurbe, A. R.
    Perez, C.
    Cuende, E.
    Galindez, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1215 - 1215
  • [33] Role of biological therapy for inflammatory bowel disease in developing countries
    Arebi, Naila
    GUT, 2013, 62 (02) : 334 - 334
  • [34] Optimizing the use of biological therapy in patients with inflammatory bowel disease
    Moss, Alan C.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 63 - 68
  • [35] The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease
    Kanai, Takanori
    Hibi, Toshifumi
    Watanabe, Mamoru
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (05) : 453 - 466
  • [36] The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease
    Larsen, Lone
    Jensen, Michael Dam
    Larsen, Michael Due
    Nielsen, Rasmus Gaardskaer
    Thorsgaard, Niels
    Vind, Ida
    Wildt, Signe
    Kjeldsen, Jens
    CLINICAL EPIDEMIOLOGY, 2016, 8 : 607 - 612
  • [37] The gut microbiota during biological therapy for inflammatory bowel disease
    Caenepeel, C.
    Viera-Silva, S.
    Verstockt, B.
    Machiels, K.
    Davani, N. A.
    Sabino, J.
    Ferrante, M.
    Raes, J.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S016 - S018
  • [38] Biological Therapy in the Elderly with Inflammatory Bowel Disease: Narrative Review
    Navas, Erika Geraldine Guarin
    Serna, Claudia Patricia Zuluaga
    UNIVERSITAS MEDICA, 2023, 64 (04): : 9 - 11
  • [39] Dual Biological Therapy in Paediatric Population With Inflammatory Bowel Disease
    Kierkus, Jaroslaw
    Wlazlo, Magdalena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S788 - S788
  • [40] The economics of biological therapy for inflammatory bowel disease and the case for equality
    Selinger, Christian
    Hall, Barry
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (10): : 650 - 651
12345